Search

Your search keyword '"Kataja V."' showing total 131 results

Search Constraints

Start Over You searched for: Author "Kataja V." Remove constraint Author: "Kataja V." Database OAIster Remove constraint Database: OAIster
131 results on '"Kataja V."'

Search Results

1. ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care:a prospective multicenter study

2. Predicting Objective Response Rate (ORR) in Immune Checkpoint Inhibitor (ICI) Therapies with Machine Learning (ML) by combining clinical and patient-reported data

3. Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies

4. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

5. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

6. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

7. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

8. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

9. Body mass index and breast cancer survival

10. Body mass index and breast cancer survival: a Mendelian randomization analysis

11. Body mass index and breast cancer survival:a Mendelian randomization analysis

14. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

15. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

16. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

17. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

18. Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers

19. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

20. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

21. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

22. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

23. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

24. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

25. Prediction of breast cancer risk based on profiling with common genetic variants

26. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

27. Identification of novel genetic markers of breast cancer survival

28. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

29. Common germline polymorphisms associated with breast cancer-specific survival

30. Annexin A1 expression in a pooled breast cancer series: Association with tumor subtypes and prognosis

31. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

32. The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients

33. Identification of Novel Genetic Markers of Breast Cancer Survival

34. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

35. Common germline polymorphisms associated with breast cancer-specific survival

36. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

37. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

38. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

39. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

40. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

41. Common germline polymorphisms associated with breast cancer-specific survival

42. Identification of Novel Genetic Markers of Breast Cancer Survival

43. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

44. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

45. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

46. Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1

47. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

48. Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions

49. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

50. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: A case-control study

Catalog

Books, media, physical & digital resources